Announcements Trials

Browse Landscape

Phase

Phase 2 88 Phase NA 23 Phase 1 22 Phase 3 20 Phase 1/2 17 Phase EARLY_PHASE1 4 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

NIH 2 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 91 Neoplasms 75 Prostatic Neoplasms 54 Carcinoma, Hepatocellular 53 Colorectal Neoplasms 49 Leukemia, Myeloid, Acute 41 Stomach Neoplasms 36 Carcinoma, Non-Small-Cell Lung 36 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Neoplasm Metastasis 29 Pancreatic Neoplasms 27 Lung Neoplasms 26 Rectal Neoplasms 23 Multiple Myeloma 21 Hematologic Neoplasms 21 Head and Neck Neoplasms 20 Colonic Neoplasms 20 Recurrence 19 Lymphoma 19 Leukemia 19 Polycystic Ovary Syndrome 16 Liver Neoplasms 14 Esophageal Neoplasms 14 Brain Neoplasms 13 Myelodysplastic Syndromes 12 Melanoma 12 Endometrial Neoplasms 12 Uterine Cervical Neoplasms 11 Motor Activity 11 Fatigue 11

Interventions

Pemetrexed 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER × Adenocarcinoma of Lung × Clear all

NCT03380468 2023-07-20

ECTOP-1004

Fudan University

Phase 2/3 Unknown

Adenocarcinoma of Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡